PAPER Diamandis EP, Yousef GM, Petraki C, Soosaipillai AR

Human kallikrein 6 as a biomarker of alzheimer's disease.

Clin Biochem. 2000 Nov;33(8):663-7. PubMed.

PAPER Dorrell S

Alzheimer's disease- a metallic problem.

Drug Discov Today. 2001 Jan 1;6(2):61-62. PubMed.

PAPER Adams DD, Lucas WO, Williams BG, Berkeley BB, Turner KW, Schofield JC

A mouse genetic locus with death clock and life clock features.

Mech Ageing Dev. 2001 Feb;122(2):173-89. PubMed.

PAPER Yao Z, Drieu K, Papadopoulos V

The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands.

Brain Res. 2001 Jan 19;889(1-2):181-90. PubMed.

PAPER Richard F, Amouyel P

Genetic susceptibility factors for Alzheimer's disease.

Eur J Pharmacol. 2001 Jan 19;412(1):1-12. PubMed.

PAPER Nacmias B, Tedde A, Cellini E, Forleo P, Orlacchio A, Guarnieri BM, Petruzzi C, D'Andrea F, Serio A, Sorbi S

Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease.

Neurosci Lett. 2001 Feb 16;299(1-2):9-12. PubMed.

PAPER Rösler N, Wichart I, Jellinger KA

Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients.

Neurosci Lett. 2001 Feb 16;299(1-2):117-20. PubMed.

PAPER Lee D, Lee EK, Lee JH, Chang CS, Paik SR

Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue.

Eur J Biochem. 2001 Jan;268(2):295-301. PubMed.

PAPER Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE, Miller CC

p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.

Eur J Neurosci. 2001 Jan;13(2):241-7. PubMed.

PAPER Vanderklish PW, Bahr BA

The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.

Int J Exp Pathol. 2000 Oct;81(5):323-39. PubMed.

PAPER Temple V, Jozsvai E, Konstantareas MM, Hewitt TA

Alzheimer dementia in Down's syndrome: the relevance of cognitive ability.

J Intellect Disabil Res. 2001 Feb;45(Pt 1):47-55. PubMed.

PAPER Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE

Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.

Synapse. 2001 Mar 15;39(4):275-87. PubMed.

PAPER Guise S, Braguer D, Carles G, Delacourte A, Briand C

Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.

J Neurosci Res. 2001 Feb 1;63(3):257-67. PubMed.

PAPER Friedman WJ

Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia.

Exp Neurol. 2001 Mar;168(1):23-31. PubMed.

PAPER Muma NA, Lee JM, Gorman L, Heidenreich BA, Mitrovic I, Napier TC

6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.

Exp Neurol. 2001 Mar;168(1):135-43. PubMed.